103
Views
12
CrossRef citations to date
0
Altmetric
REGULAR ARTICLES

Illicit Use of Opioids: Is OxyContin® a “Gateway Drug”?

, PhD, , MPH, , PhD, , MPH, , MPH, , PhD, , MPH, , MPH, , MA, , , PhD, , MPH, , MPH, , MA, , & , PhD show all
Pages 166-173 | Received 27 Sep 2006, Accepted 22 Jan 2007, Published online: 10 Jul 2009

REFERENCES

  • Woolf C, Hashmi M. Use and abuse of opioid analgesics: potential methods to prevent and deter non-medical consumption of prescription opioids. Current Opinions on Investigative Drugs. 2004;5:61–66.
  • Merline A, O'Malley P, Schulenberg J, Bachman J, Johnston L. Substance use among adults 35 years of age: prevalence, adulthood predictors, and impact of adolescent substance use. Am J Public Health. 2004;94:96–102.
  • Katz D, Hays L. Adolescent OxyContin abuse. J Am Acad Child Adoles Psychiatry. 2004;43:231–234.
  • Purdue Pharma L.P. Package insert; 2003.
  • Roche T. The potent perils of a miracle drug. Time. January 8, 2001;47.
  • Center for Substance Abuse Treatment. OxyContin: Prescription drug abuse. CSAT Advisory: Breaking news for the treatment field. April 1, 2001. Retrieved from http://www.ncadi.samhsa.gov/govpubs/ms726/ on March 1, 2006.
  • Office of National Drug Control Policy. Pulse check: trends in drug abuse. November, 2002. Retrieved from http://www.whitehousedrugpolicy.gov/publications/drugfact/pulsechk/nov02/pulse_nov02.pdf on March 1, 2006.
  • Jenkins P. Synthetic Panics: The Symbolic Politics of Designer Drugs. New York: New York University Press; 1999.
  • Gunderson E. No data to show link between opioid abuse and heroin use. Am Fam Physician. 2003;68:2134–2137, 2140.
  • Siegal H, Carlson R, Kenna D, Swora M. Probable relationship between opioid abuse and heroin use. Am Fam Physician. 2003;67:942–945.
  • Hays L. A profile of OxyContin addiction. J Addict Dis. 2004;23:1–9.
  • Sees KL, DiMarino ME, Ruediger NK, Sweeney CT, Shiffman S. Non-medical use of OxyContin tablets in the United States. J Pain Palliat Care Pharmacother. 2005;19:13–23.
  • Substance Abuse Services Commission. Oxycontin Abuse: Maine's Newest Epidemic. Augusta, Maine: Office of Substance Abuse, Maine Department of Behavioral and Developmental Services; January, 2002.
  • Alcohol & Drug Abuse Weekly. Maine analysis demonstrates far-reaching harm from OxyContin. Alcohol & Drug Abuse Weekly, 2002:1.
  • Clines F, Meier B. Cancer painkillers pose new abuse threat. New York Times. February 9, 2001;1,21.
  • Ordway R. Narcotics abuse on rise, pharmaceutical drug fraud, misuse worry officials. Bangor Daily News. April 6, 2000;4.
  • Kalb C. Playing with painkillers. Newsweek. April 9, 2001;44.
  • Kleiner C. A curse and a cure. U.S. News & World Report. August 6, 2001;131:42–43.
  • Office of National Drug Control Policy. Pulse check: trends in drug abuse. November, 2001. Retrieved from: http://www.whitehousedrugpolicy.gov/publications/drugfact/pulsechk/fall2001/index.html on July 14, 2006.
  • Conway A. A Public Health Strategic Plan to Address Opiate Abuse and Overdose: A Report from MCPH/MPHA/OSA Opiate Abuse and Overdose Project. Augusta, Maine: Maine Center for Public Health; 2001.
  • Maxwell J. Evaluation of the Acadia Narcotic Treatment Program. Austin, Tex.: Center for Social Work Research; 2002.
  • Broadhead R, Heckathorn D, Grund J-P, Stern L, Anthony D. Drug users versus outreach workers in combatting AIDS: preliminary evidence of a peer-driven intervention. Journal on Drug Issues. 1995;23:531–564.
  • Heckathorn D, Broadhead R, Anthony D, Weakliem D. AIDS and social networks: prevention through network mobilization. Sociological Focus. 1999;32:159–179.
  • Heckathorn D. Respondent driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Social Problems. 2002;49:11–34.
  • Semaan S, Lauby J, Liebman J. Street and network sampling in evaluation studies of HIV risk-reduction interventions. AIDS Rev. 2002;4:213–223.
  • National Institute on Drug Abuse. Risk Behavior Assessment. Rockville, Md.: NIDA; 1991.
  • Heimer R, Buchanan D, Teng W, Stopka T, Khoshnood K, Singer M. Effects of increasing syringe availability on syringe exchange use and HIV risk: Connecticut, 1990–2001. J Urban Health. 2002;79:556–569.
  • Heimer R, Clair S, Grau L, Bluthenthal R, Marshall P, Singer M. Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities. Addiction. 2002;97:1277–1287.
  • McLellan A, Luborsky L, O'Brien C, Woody G. An improved diagnostic instrument for substance abuse patients, the Addiction Severity Index. J Nerv Ment Dis. 1980;168:26–33.
  • Kosten T, Rounsaville B, Kleber H. Concurrent validity of the Addiction Severity Index. J Nerv Ment Dis. 1983;17:606–610.
  • McLellan A, Kushner H, Metzger D, , et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9:199–213.
  • Cleeland C. Measurement of pain by subjective report. In: Chapman C, Loeser J, eds. Advances in Pain Research and Therapy: Issues in Pain Management. Vol 12. New York: Raven Press; 1989:391–403.
  • U. S. Census Bureau. Census 2000 Summary File 3. Washington, DC: 2000.
  • State of Maine Report. OxyContin Abuse: Maine's Newest Epidemic. Augusta, Maine: Substance Abuse Services Commission in Conjunction with the Maine Office of Substance Abuse; January, 2002.
  • Pochna P. New drug of choice sweeps state: painkiller OxyContin. Portland Press Herald. July 30, 2000; B1.
  • Hench D. Drug use suspected in three local deaths. Portland Press Herald. August 15, 2000; A1.
  • Zacny J, Bigelow G, Compton P, Foley K, Iguchi M, Sannerud C. College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend. 2003;69:215–232.
  • Portland Press Herald. Briefly: Two men rob S. Portland family of cash, pills. Portland Press Herald. June 29, 2000; B1.
  • Goodwin R, Hasin D. Sedative use and misuse in the United States. Addiction. 2002;97:555–562.
  • Simoni-Wastila L, Strickler G. Risk factors associated with problem use of prescription drugs. Am J Public Health. 2004;94:266–267.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.